BOON HUAT LIM,NURULHASANAH OTHMAN,RAHMAH BINTI NOORDIN,WENG KIN WONG,ZEEHAIDA MOHAMED,ZI NING TAN
申请号:
BR112014000135
公开号:
BR112014000135A2
申请日:
2011.07.20
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
An in vitro method of diagnosing and/or treating at least one subject as having or as being at risk of having Entamoeba histolytica (E. histolytica) infection, the method comprising detecting the presence of at least one E. histolytica protein, fragment, variant or mutant thereof in a serum sample from the subject, wherein the presence of the protein, fragment, variant or mutant thereof is indicative of the subject having or as being at risk of having E. histolytica infection.